FOLD icon

Amicus Therapeutics

257 hedge funds and large institutions have $2.74B invested in Amicus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 96 increasing their positions, 77 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

17% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 63

58% less capital invested

Capital invested by funds: $6.44B → $2.74B (-$3.71B)

Holders
257
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26.6M
Puts
$21.6M
Net Calls
Net Calls Change

Top Sellers

1 -$154M
2 -$31.2M
3 -$31.1M
4
Morgan Stanley
Morgan Stanley
New York
-$27.3M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$26.3M
Name Holding Trade Value Shares
Change
Change in
Stake
176
$192K
177
$180K
178
$176K
179
$173K
180
$170K
181
$168K
182
$164K
183
$160K
184
$154K
185
$152K
186
$149K
187
$137K
188
$133K
189
$131K
190
$129K
191
$127K
192
$126K
193
$124K
194
$119K
195
$117K
196
$116K
197
$114K
198
$113K
199
$111K
200
$99K